CIK 0001527096
MIRO Miromatrix Medical Inc.
Insider trading from SEC Form 4. Last filing Dec 13, 2023.
In brief
Miromatrix Medical Inc. (MIRO) has 7 SEC Form 4 filings on file from 7 insiders, the latest filed on Dec 13, 2023. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at Miromatrix Medical Inc., scored.
Transactions
Every row filed, 35 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 12, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | UTender of shares Common Stock | -308,775 | - | - | 87,500 | Dec 13, 2023 |
| Dec 12, 2023 | Peter Maag director | UTender of shares Common Stock | -62,092 | - | - | 58,368 | Dec 13, 2023 |
| Dec 12, 2023 | Lisa Wipperman Heine director | UTender of shares Common Stock | -66,943 | - | - | 67,413 | Dec 13, 2023 |
| Dec 12, 2023 | John L Erb director | UTender of shares Common Stock | -56,260 | - | - | 54,201 | Dec 13, 2023 |
| Dec 12, 2023 | James Michael Douglas CHIEF FINANCIAL OFFICER | UTender of shares Common Stock | -31,250 | - | - | 20,000 | Dec 13, 2023 |
| Dec 12, 2023 | William P. Mr. Burke director | UTender of shares Common Stock | -66,943 | - | - | 67,413 | Dec 13, 2023 |
| Dec 12, 2023 | Paul Buckman director | UTender of shares Common Stock | -52,593 | - | - | 54,201 | Dec 13, 2023 |
| Dec 13, 2023 | Peter Maag director | DDisposition to issuer Common Stock | -58,368 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Common Stock | -87,500 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Paul Buckman director | DDisposition to issuer Common Stock | -54,201 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Lisa Wipperman Heine director | DDisposition to issuer Common Stock | -67,413 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | William P. Mr. Burke director | DDisposition to issuer Common Stock | -67,413 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | John L Erb director | DDisposition to issuer Common Stock | -54,201 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | James Michael Douglas CHIEF FINANCIAL OFFICER | DDisposition to issuer Common Stock | -20,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | John L Erb director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Paul Buckman director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | James Michael Douglas CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -180,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -41,250 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | John L Erb director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,750 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Paul Buckman director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -18,750 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -43,750 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | James Michael Douglas CHIEF FINANCIAL OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -40,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -33,688 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Paul Buckman director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | John L Erb director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -39,375 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Paul Buckman director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | John L Erb director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | John L Erb director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Paul Buckman director | DDisposition to issuer Employee Stock Option (right to buy)derivative | -25,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -68,714 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -1,500 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Dec 13, 2023 |
| Dec 13, 2023 | Jeffrey James Ross CHIEF EXECUTIVE OFFICER | DDisposition to issuer Employee Stock Option (right to buy)derivative | -100,000 | - | - | 0 | Dec 13, 2023 |
Insiders
Everyone who has filed a Form 4 here.
- Paul Buckmandirector
- William P. Mr. Burkedirector
- James Michael DouglasCHIEF FINANCIAL OFFICER
- John L Erbceo, president, officer, director, owner
- Lisa Wipperman Heinedirector
- Peter Maagdirector
- Jeffrey James RossCHIEF EXECUTIVE OFFICER
Questions about MIRO
Answered from the filings on this page, as of the latest one.
Are insiders buying MIRO?
No. In the last 90 days no insider at Miromatrix Medical Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade MIRO on the open market?
No open-market trade has been scored at Miromatrix Medical Inc.. The latest Form 4 on file was filed on Dec 13, 2023 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at Miromatrix Medical Inc.?
7 people have filed a Form 4 at Miromatrix Medical Inc., among them Paul Buckman (director), William P. Mr. Burke (director), James Michael Douglas (CHIEF FINANCIAL OFFICER). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.